CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. - Wikidata - awgldk - TriplyDB

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

http://www.wikidata.org/entity/Q37565174

about

Molecular mechanisms for enhanced DNA vaccine immunogenicity.Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

P2860

Q30366743-CD64A7FE-A659-4F05-BC15-C4A4645DCC53 Q35826651-4B1F7147-6055-4740-BD69-B33D8A3559F7

P2860

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

http://www.wikidata.org/entity/Q37565174

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@en

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@nl

type

label

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@en

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@nl

prefLabel

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@en

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@nl

P1433

Q37565174-942A788A-2B84-4579-81AE-C63AF8368826

P1476

Q37565174-F830BE97-3408-48FE-A17F-472F265B16F4

P2093

Q37565174-1E5A9DF6-7F6B-40D9-A1A7-EA939076088B

Q37565174-521DFD92-3C5F-4CAA-8215-BD185A257715

Q37565174-62BBE0BB-AB52-45CC-8588-99F0ABA13DE0

Q37565174-6C1532CE-6FDF-4395-8CE4-87FA6D5CB913

Q37565174-B5F47A96-9D59-4140-AC1A-3A6573BA2356

Q37565174-D25C3FEE-2CAB-4612-B8C6-E5B3D89A6F9A

P2860

Q37565174-0AD8A479-E967-4FCA-8AD2-344D57D15928

Q37565174-302579FA-E880-43EA-91F3-44629F3C8552

Q37565174-3A5905BF-0A4C-4C6D-8D8F-5A3C0242403A

Q37565174-4D8728C1-4A40-4BFF-A546-B739419F7006

Q37565174-4F6ABFB9-2DD2-4EEC-93A6-4BB32C934353

Q37565174-503A3423-079E-4292-BFC8-41C937006909

Q37565174-66D8DC24-94A4-4B1B-A6E1-6459C6616FA3

Q37565174-6ED574C9-BE39-42A9-9241-A07791B7239E

Q37565174-72778DEA-6B74-4029-9B48-D445F34D35EC

Q37565174-74710303-72FE-4879-B153-0B3FEB86E2E4

P304

Q37565174-86757E6D-F5D0-4DE0-A1E6-EA7A5A8A8281

P31

Q37565174-1A3C3430-EBE9-490C-80AE-1F268AB66DE7

P356

Q37565174-642B99D3-5C8C-4ADE-914E-41235546058D

P433

Q37565174-57676102-C03C-4754-A100-6A59002DB0CF

P478

Q37565174-9B359798-8684-4D7C-A514-73658EC55BE0

P577

Q37565174-868F1783-F7DF-4799-B6E2-A661639BF76B

P698

Q37565174-04760050-B4D5-414D-9E83-EE09C93F6C6C

P932

Q37565174-AB3BC8D9-07DB-428A-869D-83280C8BC367

P356

P1433

Biomedical Reports

P1476

CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST.

@en

P2093

Chao-Pin Li

http://www.w3.org/2001/XMLSchema#string

Jun Lu

http://www.w3.org/2001/XMLSchema#string

Shan Jiang

http://www.w3.org/2001/XMLSchema#string

Shuai Ma

http://www.w3.org/2001/XMLSchema#string

Song Ye

http://www.w3.org/2001/XMLSchema#string

Yun Deng

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

Helminth infections: the great neglected tropical diseases

Interleukin-10: new perspectives on an old cytokine

Current status of vaccines for schistosomiasis

Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection

Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.

Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.

Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases

The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.

P304

609-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2013.99

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24648995

http://www.w3.org/2001/XMLSchema#string

P932

3916974

http://www.w3.org/2001/XMLSchema#string